Get the Stockscreener App
2.59
0.78%
0.02
Traws Pharma Inc stock is traded at $2.59, with a volume of 25,586.
It is up +0.78% in the last 24 hours and up +15.11% over the past month.
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
See More
Previous Close:
$2.57
Open:
$2.56
24h Volume:
25,586
Relative Volume:
0.15
Market Cap:
$18.29M
Revenue:
$2.90M
Net Income/Loss:
$87.91M
P/E Ratio:
0.1659
EPS:
15.6103
Net Cash Flow:
$-26.93M
1W Performance:
-0.38%
1M Performance:
+15.11%
6M Performance:
+82.39%
1Y Performance:
-48.10%
1-Day Range:
$2.53
$2.6701
1-Week Range:
$2.47
$3.10
52-Week Range:
$0.97
$19.44
Traws Pharma Inc Stock (TRAW) Company Profile
Name
Traws Pharma Inc
Sector
Industry
Phone
267-759-3680
Address
12 PENNS TRAIL, NEWTOWN
Compare TRAW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
2.5899 | 18.31M | 2.90M | 87.91M | -26.93M | 15.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.02 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.18 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.84 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.89 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-22 | Initiated | Ladenburg Thalmann | Buy |
| May-18-21 | Initiated | Guggenheim | Buy |
| Mar-01-18 | Reiterated | H.C. Wainwright | Buy |
| Jan-17-18 | Downgrade | Maxim Group | Buy → Hold |
| Oct-09-17 | Initiated | H.C. Wainwright | Buy |
| Apr-27-17 | Initiated | Laidlaw | Buy |
| Jul-01-15 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-15 | Initiated | H.C. Wainwright | Buy |
View All
Traws Pharma Inc Stock (TRAW) Latest News
Why ETFs are accumulating Traws Pharma Inc. (0T20) stockIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Visualizing Traws Pharma Inc. stock with heatmapsTrade Performance Summary & Consistent Income Trade Ideas - newser.com
Measuring Traws Pharma Inc.’s beta against major indicesWatch List & Fast Gaining Stock Strategy Reports - newser.com
What the charts say about Traws Pharma Inc. todayExit Point & Stepwise Trade Signal Guides - newser.com
Using RSI to spot recovery in Traws Pharma Inc.2025 Top Decliners & Weekly Top Gainers Alerts - newser.com
Is Traws Pharma Inc. (0T20) stock supported by free cash flowJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
Is Traws Pharma Inc. (0T20) stock testing key supportJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - newser.com
Live market analysis of Traws Pharma Inc.2025 Support & Resistance & Advanced Technical Signal Analysis - newser.com
What technical models suggest about Traws Pharma Inc.’s comebackEarnings Growth Report & Risk Controlled Daily Plans - newser.com
Will Traws Pharma Inc. (0T20) stock extend growth storyJuly 2025 Fed Impact & Consistent Profit Alerts - newser.com
Price action breakdown for Traws Pharma Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com
Is Traws Pharma Inc. forming a reversal patternMarket Activity Report & High Accuracy Investment Signals - newser.com
Traws Pharma (NASDAQ:TRAW) Upgraded at Wall Street Zen - Defense World
Tick level data insight on Traws Pharma Inc. volatilityPortfolio Gains Summary & Breakout Confirmation Alerts - newser.com
Technical signs of recovery in Traws Pharma Inc.July 2025 Summary & Accurate Technical Buy Alerts - newser.com
Is a relief rally coming for Traws Pharma Inc. holdersWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials - MarketScreener
2025-10-30 | ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials | NDAQ:TRAW | Press Release - Stockhouse
Advanced analytics toolkit walkthrough for Traws Pharma Inc.Earnings Risk Report & Fast Gain Stock Tips - newser.com
How Traws Pharma Inc. stock reacts to inflationary pressuresWeekly Trade Report & Verified Technical Trade Signals - newser.com
Traws Pharma Inc Stock (TRAW) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):